Enliven Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
MACK
Merrimack Pharmaceuticals, Inc. |
$0.00 | $223.97 M | -168.28 | 0 |
CGEM
Cullinan Oncology, Inc. |
$8.75 | $516.08 M | -3.16 | 111 |
CELC
Celcuity Inc. |
$11.80 | $446.82 M | -3.87 | 87 |
GOSS
Gossamer Bio, Inc. |
$1.26 | $257.99 M | -5.16 | 144 |
KRON
Kronos Bio, Inc. |
$0.87 | $40.94 M | -0.65 | 8 |
INBX
Inhibrx Biosciences, Inc. |
$12.96 | $198.90 M | 0.12 | 156 |
IMRX
Immuneering Corporation |
$1.99 | $61.00 M | -0.86 | 54 |
GPCR
Structure Therapeutics Inc. |
$21.45 | $429.22 M | -8.67 | 163 |
AVTE
Aerovate Therapeutics, Inc. |
$2.68 | $77.68 M | -0.05 | 4 |
MLTX
MoonLake Immunotherapeutics |
$48.79 | $2.47 B | -16.92 | 100 |
CMPX
Compass Therapeutics, Inc. |
$2.36 | $326.35 M | -5.9 | 35 |
NVCT
Nuvectis Pharma, Inc. |
$8.95 | $196.82 M | -8.34 | 13 |
REPL
Replimune Group, Inc. |
$9.81 | $723.84 M | -3.06 | 479 |
THRX
Theseus Pharmaceuticals, Inc. |
$0.00 | $181.50 M | -3.03 | 38 |
PMVP
PMV Pharmaceuticals, Inc. |
$0.94 | $46.41 M | -0.76 | 47 |
LYRA
Lyra Therapeutics, Inc. |
$25.43 | $6.76 M | -0.08 | 30 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
